NewsRx

Search our medical news database

Vaccine Development (HSV-2)

Nucleic Acid Vaccine Protects Mice from Herpes Simplex Virus-2

Published in Vaccine Weekly, March 11th, 1996

A nucleic acid vaccine encoding the gD2 envelope glycoprotein sequence protected mice against challenge with herpes simplex virus type 2 (HSV-2).

The gD2 envelope glycoprotein of HSV-2 has an important role in the attachment and penetration of the virus into the host cells. It has been shown that serum antibodies against gD develop naturally in all patients infected with HSV-2. T cells that specifically respond to gD have also been isolated from HSV infected mice.

Monoclonal antibodies directed against HSV gD have been shown to provide passive immunity against the disease in animal models. HSV prophylactic subunit vaccines containing gD2 have been...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook